S100A12 and COVID-19: Interestingly, S100A12-TLR4 signal pathway also was enriched in severe COVID-19 patients relative to mild and healthy donors (Supplementary Fig. 4j), suggesting that this signal pathway may also contribute to the development of severe disease.